PharmaSGP Holding SE

XTRA:PSG Rapport sur les actions

Capitalisation boursière : €242.2m

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

PharmaSGP Holding Gestion

Gestion contrôle des critères 3/4

We currently do not have sufficient information about the CEO.

Informations clés

Natalie Weigand

Directeur général

€865.0k

Rémunération totale

Pourcentage du salaire du PDG34.7%
Durée du mandat du directeur général4.4yrs
Propriété du PDGn/a
Durée moyenne d'occupation des postes de direction4.4yrs
Durée moyenne du mandat des membres du conseil d'administration4.4yrs

Mises à jour récentes de la gestion

Recent updates

Shareholders Will Be Pleased With The Quality of PharmaSGP Holding's (ETR:PSG) Earnings

May 06
Shareholders Will Be Pleased With The Quality of PharmaSGP Holding's (ETR:PSG) Earnings

Some Shareholders Feeling Restless Over PharmaSGP Holding SE's (ETR:PSG) P/E Ratio

Mar 02
Some Shareholders Feeling Restless Over PharmaSGP Holding SE's (ETR:PSG) P/E Ratio

PharmaSGP Holding SE Just Beat Revenue Estimates By 25%

Dec 02
PharmaSGP Holding SE Just Beat Revenue Estimates By 25%

One Analyst Just Shaved Their PharmaSGP Holding SE (ETR:PSG) Forecasts Dramatically

Feb 16
One Analyst Just Shaved Their PharmaSGP Holding SE (ETR:PSG) Forecasts Dramatically

We Think PharmaSGP Holding's (ETR:PSG) Statutory Profit Might Understate Its Earnings Potential

Jan 26
We Think PharmaSGP Holding's (ETR:PSG) Statutory Profit Might Understate Its Earnings Potential

Do Institutions Own PharmaSGP Holding SE (ETR:PSG) Shares?

Dec 04
Do Institutions Own PharmaSGP Holding SE (ETR:PSG) Shares?

Analyse de la rémunération des PDG

Comment la rémunération de Natalie Weigand a-t-elle évolué par rapport aux bénéfices de PharmaSGP Holding?
DateRémunération totaleSalaireBénéfices de l'entreprise
Mar 31 2024n/an/a

€18m

Dec 31 2023€865k€300k

€16m

Sep 30 2023n/an/a

€15m

Jun 30 2023n/an/a

€14m

Mar 31 2023n/an/a

€13m

Dec 31 2022€314k€250k

€12m

Sep 30 2022n/an/a

€11m

Jun 30 2022n/an/a

€11m

Mar 31 2022n/an/a

€11m

Dec 31 2021€272k€250k

€11m

Sep 30 2021n/an/a

€8m

Jun 30 2021n/an/a

€8m

Mar 31 2021n/an/a

€9m

Dec 31 2020€279k€258k

€11m

Sep 30 2020n/an/a

€16m

Jun 30 2020n/an/a

€17m

Mar 31 2020n/an/a

€17m

Dec 31 2019€141k€141k

€17m

Rémunération vs marché: Natalie's total compensation ($USD958.87K) is about average for companies of similar size in the German market ($USD804.67K).

Rémunération et revenus: Natalie's compensation has increased by more than 20% in the past year.

PDG

Natalie Weigand (43 yo)

4.4yrs

Titularisation

€865,000

Compensation

Ms. Natalie Weigand serves as the Chief Executive Officer at PharmaSGP Holding SE since June 2020 and also serves as a Member of Management Board since March 04, 2020. She joined the FUTRUE Group as the le...

Équipe de direction

NomPositionTitularisationCompensationPropriété
Natalie Weigand
CEO & Member of Management Board4.4yrs€865.00kpas de données
Michael Rudolf
CFO & Member of Management Board4.4yrs€879.00kpas de données
Peter Gerckens
Member of Management Boardless than a yearpas de donnéespas de données

4.4yrs

Durée moyenne de l'emploi

Gestion expérimentée: PSG's management team is considered experienced (4.4 years average tenure).

Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Axel Rebien
Member of the Supervisory Board4.2yrs€50.00kpas de données
Madlena Hohlefelder
Deputy Chairwoman of the Supervisory Board4.4yrspas de données48.95%
€ 118.6m
Clemens Fischer
Chairman of the Supervisory Board4.4yrspas de donnéespas de données

4.4yrs

Durée moyenne de l'emploi

49yo

Âge moyen

Conseil d'administration expérimenté: PSG's board of directors are considered experienced (4.4 years average tenure).